Administration of Potential Medications for COVID-19 Treatment Through Feeding Tube
| Autor: | Kutay Demirkan, Burcu Kelleci Cakir, Oğuzhan Firat |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Oral Suspension Dosage Form business.industry Pharmaceutical Science Hydroxychloroquine Clinical nutrition Azithromycin Letter to Editor Parenteral Dosage Form Clinical pharmacy Diarrhea medicine Molecular Medicine medicine.symptom Intensive care medicine business Feeding tube medicine.drug |
| Zdroj: | Turk J Pharm Sci |
| Popis: | If the oral suspension dosage form is not available, opening up the oseltamivir capsule is recommended. Since remdesivir is only available in a parenteral dosage form, it cannot be administered via FT.4 Even though hydroxychloroquine with/without azithromycin treatment is not preferred in current clinical practice, it is still recommended in some local treatment algorithms of COVID-19. Total daily sorbitol amount over 20 g might cause diarrhea, therefore if liquid dosage form of any of medication is preferred, the amount of its sorbitol ingredient needs to be considered (2). [...]if clinicians are unaware of sorbitol related diarrhea, this might mislead their clinical judgment.1 None of these medications is confirmed for COVID-19 treatment yet, thus many countries published various treatment algorithms. [...]administration of these medications through FT should be the part of these possible treatment algorithms or guidelines. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|